Table 1.
Summary of patient and subject clinical parameters.
| Primary HIV (n = 6) | HIV cART (n = 6) | HIV controllers (n = 6) | Healthy (n = 6) | |
|---|---|---|---|---|
|
Age median (min-max), in years |
34 (24–47) |
35 (25–48) |
39 (25–49) |
35 (25–45) |
| Gender | M | M | M | M |
|
Days since HIV-1 diagnosis median (min-max), in days |
28 (18–29) |
361 (290–372) |
1,825 (1,825–7,300) |
N/A |
| Treatment | Naive | cART | Naive | Naive |
|
RNA HIV load at diagnosis median (min-max), in log10 copies/ml of plasma |
6.67 (5.47–7.26) |
1 (1–1.63) |
1.54 (1.43–1.69) |
N/A |
|
CD4 T-cell count median (min-max), in 103 cells/μl of blood |
470 (258–669) |
843 (570–1,247) |
827 (652–1,180) |
856 (634–1,412) |
Eighteen Caucasian men were involved in this study to constitute four groups of conditions. These groups are composed of six primary HIV-infected patients before treatment (primary HIV) and after 1 year of combination antiretroviral therapy (HIV cART), six elite controllers (HIV controllers), and six healthy subjects (Healthy). The gender and median patient age, days since HIV-1 diagnosis, RNA viral load, and CD4+ T-cell count are indicated for each group. cART, combination antiretroviral therapy; N/A, not applicable; M, male.